An antidepressant medication named duloxetine has been recalled by the U.S. Food and Drug Administration (FDA) due to the presence of carcinogenic chemicals. The drug was voluntarily recalled by a ...
A recent Food and Drug Administration (FDA) recall of a commonly prescribed antidepressant, Duloxetine, because it may contain a potentially cancer-causing agent that could impact the health of ...
The U.S. Food and Drug Administration classified capsules of duloxetine, sold by New Jersey-based company Rising Pharmaceuticals, as a Class II risk on Dec. 5. The risk level is the FDA's second ...
For diabetic peripheral neuropathic pain, the recommended dosage is 60 mg per day, although dosages of up to 120 mg daily have been studied. [25] Higher dosages do not have proven benefit and may ...
according to the Food and Drug Administration. On Nov. 19, various doses of duloxetine delayed-release capsules manufactured by Rising Pharma, Inc., were recalled due to the "presence of N-nitroso ...
Cymbalta (duloxetine) is a brand-name prescription antidepressant drug that is administered in the form of an oral capsule. Cymbalta belongs to the serotonin-norepinephrine reuptake inhibitors (SNRIs) ...